United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
4h
Zacks.com on MSNUTHR or ZTS: Which Is the Better Value Stock Right Now?But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. Everyone has their own methods for finding great value opportunities, but ...
It is hard to get excited after looking at United Therapeutics' (NASDAQ:UTHR) recent performance, when its stock ...
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...
Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...
Get Our Latest Analysis on United Therapeutics United Therapeutics Price Performance NASDAQ UTHR opened at $351.17 on Friday. United Therapeutics Co. has a 12 month low of $208.62 and a 12 month ...
United Therapeutics could eventually use the genetically edited swine to grow organs for human transplant recipients. A ...
Is United Therapeutics (UTHR) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this ...
UTHR boasts a Value Style Score of A and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. Shares of United Therapeutics are trading at a forward earnings multiple of 12.8X, as well as a PEG ...
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results